Tag Archives: AI drug discovery

January 5, 2022
Atomwise Invited to Present at the 2022 J.P. Morgan Healthcare Conference
Press Release

Leading AI-pharma company among select few private companies to participate San Francisco, CA – January 5, 2022 – Atomwise, a technology-enabled pharmaceutical company leveraging the power of artificial intelligence (AI) to revolutionize small molecule drug discovery, today announced that it has been invited to present next week at the 40th Annual J.P. Morgan Healthcare Conference. […]

Read Article
September 13, 2021
Biopharma AI Collaborations Driving Innovative Change in Drug Development
In The News
Read Article
August 17, 2021
Special Report: Seeking intelligence
In The News
Read Article
June 24, 2021
5 companies harnessing AI for drug discovery to watch
In The News
Read Article
June 17, 2021
Atomwise Adds Pharma Luminaries to Board of Directors and Scientific Advisory Board
Press Release

Experts include Mike Varney, Bruce Roth, John Hamer, Kemal Malik, and Andrew Lo SAN FRANCISCO, Calif., June 17, 2021 – Atomwise has strengthened its drug discovery and development expertise by expanding its Board of Directors and creating a Scientific Advisory Board (SAB). These appointments signal a critical milestone for Atomwise as the company focuses on […]

Read Article
June 15, 2021
Top AI Startups & Scaleups 2021: Trailblazers With Promise And Real-World Potential
In The News
Read Article